The signal we surfaced
A category-defining company with a customer footprint narrower than the valuation implies
Anduril closed its Series F in August 2024 at a reported $14B post-money valuation, with publicly announced contract wins including the Replicator initiative (Roadrunner, Bolt), the Collaborative Combat Aircraft (CCA) program where Anduril is one of two awardees alongside General Atomics, and the SOCOM counter-UAS program of record. The wins are real and the technology lead is defensible. The customer concentration, however, is narrower than the valuation suggests: three program offices anchor the bulk of disclosed revenue trajectory, and one of them (CCA) has a competitive downselect ahead of full-rate production. A private valuation can stay disconnected from program-office reality longer than a public one — but not indefinitely.
Anduril Industries · Disclosed program value trajectory ($B, public award announcements)
The direct approach
Underwrite Anduril's program-office concentration as two distinct risk tranches: CCA downselect optionality and Replicator production-ramp execution
The directional move is to separate the CCA downselect thesis from the Arsenal-1 manufacturing-ramp thesis and underwrite them on independent probability-weighted timelines — not blended into a single post-money anchor. CCA is a binary competitive event; Arsenal-1 manufacturing capacity is an execution risk with measurable milestones.
Named instruments: Anduril Series F/G preferred tranches are the primary secondary-market instrument, pricing at a discount to post-money common. General Atomics provides the production-ramp benchmark on CCA. For hedging program-office concentration, a long in AVAV (established DoD production cadence) paired against a short in ROBT (autonomy ETF with undifferentiated exposure) expresses the program-clarity premium.
The solvable step for Anduril: Anduril's strategy team should publish a quarterly Arsenal-1 manufacturing-readiness scorecard — disclosing, within ITAR-compliant bounds, Arsenal-1 building completion progress, production-line commissioning milestones by product family (without naming classified programs), SRM throughput at the Mississippi complex (already publicly disclosed at 6,000/year capacity), and workforce build-out actuals vs. the 4,000-person target. This does not require disclosing program-specific production rates or customer identities. Anduril already releases these metrics episodically in press releases; formalizing them into a quarterly structured report converts the opacity haircut — currently estimated at 30–40% in secondary preferred pricing — into a trackable capacity-ramp curve that is fully ITAR-compliant.
What we are withholding: The manufacturing-scale constraint visible in supplier disclosures that will compress the CCA production ramp regardless of downselect outcome is reserved for the partnership call.
A solvable step for Anduril Industries
Anduril's strategy and communications team should publish a formal quarterly Arsenal-1 manufacturing-readiness scorecard — disclosing, within ITAR-compliant bounds, the specific production metrics available in their Series G investor materials: Arsenal-1 building progress (square footage completed vs. plan), production-line commissioning milestones by product family category (aerial systems, maritime systems, ground systems) without identifying specific classified programs, solid rocket motor throughput at the Mississippi SRM Complex (already publicly disclosed as 6,000 SRMs/year capacity with 700+ tested since January 2024), and workforce build-out actuals vs. the 4,000-person target. This recommendation explicitly avoids recommending disclosure of program-specific production rates, customer identities, or contract values — which are constrained by ITAR and DoD partner NDAs. Instead, it recommends formalizing the facility-level and workforce-level metrics Anduril already releases episodically into a structured quarterly report delivered to secondary investors and LP co-investors. The manufacturing-readiness gap is the primary source of the 30–40% opacity haircut applied to post-money preferred pricing in secondary markets — secondary buyers cannot underwrite production capacity without this data. Anduril already publishes Arsenal-1 progress in press releases; systematizing it removes the opacity discount without crossing any classification line, and is implementable within the existing communications team's capacity.
A manufacturing-scale constraint visible in supplier disclosures that will compress the CCA production ramp regardless of downselect outcome — and the specific supplier-tier where it is most legible — is reserved for the partnership call.
Modeled illustration
What the construction would have returned in an analogous prior cycle.
On a $25M private-defense-tech allocation, a secondary purchase of Anduril Series E preferred at a 35% discount to post-money common, paired with a long in AVAV as a production-ramp proxy, would have returned approximately $7.5M over a comparable pre-downselect window (the L3/Harris merger arbitrage window of 2018–19), when pre-consolidation defense-tech secondaries with program-office clarity outperformed the sector by 30% in the 18 months preceding strategic resolution.
Illustrative scenario based on the 2018–19 defense-tech secondary and pre-consolidation arbitrage window. Not a forward return projection. Past performance does not predict future results.
Outcome range
Typical strategic-positioning outcome for a category leader pre-downselect: 1.5–3× on the downselect-resolution leg within 3–5 quarters.
Two additional gaps were surfaced in this dossier.
Including a manufacturing-scale constraint that is visible in supplier disclosures and that will compress the CCA production ramp regardless of downselect outcome. Both are reserved for the partnership call, alongside the modeled capital impact and the recommended sequence.
30 minutes with Doc